These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 26129705)

  • 1. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
    Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
    Headache; 2015; 55(7):984-91. PubMed ID: 26129705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Levels of Oxidative Stress Markers, before and after
    Dini E; Mazzucchi S; De Luca C; Cafalli M; Chico L; Lo Gerfo A; Siciliano G; Bonuccelli U; Baldacci F; Gori S
    Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31635021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
    Vieira DS; Naffah-Mazzacoratti Mda G; Zukerman E; Senne Soares CA; Cavalheiro EA; Peres MF
    Headache; 2007 Jun; 47(6):842-7. PubMed ID: 17578532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of RAMP1 rs7590387 with the risk of migraine transformation into medication overuse headache.
    Cargnin S; Pautasso C; Viana M; Sances G; Mittino D; Cantello R; Tassorelli C; Nappi G; Terrazzino S
    Headache; 2015 May; 55(5):658-68. PubMed ID: 25881990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frovatriptan possibly causing acute myocardial infarction].
    Møller-Helgestad OK; Kaltoft AK; Kasch H
    Ugeskr Laeger; 2015 Mar; 177(13):V10140537. PubMed ID: 25822816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
    Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cerebral responses to salient transitions between alternating stimuli in chronic migraine with medication overuse headache and during migraine attacks.
    Bogdanov VB; Bogdanova OV; Viganò A; Noirhomme Q; Laureys S; Dallel R; Phillips C; Schoenen J
    Cephalalgia; 2019 Jul; 39(8):988-999. PubMed ID: 30786732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and differences between chronic migraine and episodic migraine.
    Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
    Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Self-medication of regular headache: a community pharmacy-based survey in Belgium].
    Mehuys E; Paemeleire K; Van Hees T; Christiaens T; Van Bortel L; Van Tongelen I; Philippe G; Prévôt ML; Evrard B; Piette M; De Bolle L; Remon JP; Boussery K
    J Pharm Belg; 2012 Jun; (2):4-10. PubMed ID: 22978009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and mechanisms of chronic migraine and medication-overuse headache].
    Takeshima T
    Rinsho Shinkeigaku; 2010 Nov; 50(11):990-3. PubMed ID: 21921539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
    Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
    J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
    Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
    Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
    Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients.
    Di W; Shi X; Zhu Y; Tao Y; Qi W; Luo N; Xiao Z; Yi C; Miao J; Zhang A; Zhang X; Fang Y
    Eur J Neurol; 2013 Apr; 20(4):655-62. PubMed ID: 23114018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal.
    Grazzi L; D'Amico D; Raggi A; Leonardi M; Ciusani E; Corsini E; D'Andrea G; Bolner A; Salgado-García F; Andrasik F; Sansone E
    Neurol Sci; 2017 May; 38(Suppl 1):173-175. PubMed ID: 28527073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of leukocytes in medication-overuse headache, chronic migraine, and episodic migraine.
    Forcelini CM; Dantas DC; Luz C; Santin R; Stein AT; Barros HM; Barea LM
    Headache; 2011 Sep; 51(8):1228-38. PubMed ID: 21649652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of endocannabinoids in chronic migraine and medication overuse headache.
    Cupini LM; Costa C; Sarchielli P; Bari M; Battista N; Eusebi P; Calabresi P; Maccarrone M
    Neurobiol Dis; 2008 May; 30(2):186-9. PubMed ID: 18358734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients.
    Ferrari A; Savino G; Gallesi D; Pinetti D; Bertolini A; Sances G; Coccia CP; Pasciullo G; Leone S; Loi M; Sternieri E
    Pharmacol Res; 2006 Aug; 54(2):142-9. PubMed ID: 16697657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.